BioFactura Announces Positive Results In Development Of New Rapid Diagnostic Tests For Viral Hemorrhagic Fever Infections And Bioterrorism Threats

BioFactura, Inc., announced that the first test kits for viral hemorrhagic fever diagnosis have completed initial clinical testing in West Africa. The clinical test kits were developed under a $3.8M grant awarded by the National Institutes of Health (NIH) and were developed by BioFactura in collaboration with Tulane University, the US Army Medical Research Institute of Infectious Diseases (USAMRIID), Corgenix Medical Corp, Autoimmune Technologies, and partners in West Africa. [click link for full article]

More: continued here

Filed under: Bio-terrorism on November 3rd, 2007